ML Model Predicts Mortality Risk in Lung Cancer
Researchers at Guangzhou Medical University and Guangzhou Chest Hospital developed a multivariate machine learning model to predict all-cause mortality in 1,278 chemotherapy-treated lung cancer patients enrolled from 2017–2019. The model retained 21 features, including MDASI-LC trajectories, TNM stage, and blood biomarkers, and achieved a concordance index of 0.702 (95% CI 0.652–0.753) with AUCs of 0.740, 0.777, and 0.915 for 1-, 3-, and 5-year mortality. Calibration, decision-curve, and interpretability analyses indicate potential utility for personalized prognostic management.
Key Points
- 1Developed a multivariate ML model using 1,278 postchemotherapy lung cancer patients, 21 predictive features.
- 2Achieved acceptable discrimination with C-index 0.702 and AUCs 0.740, 0.777, 0.915.
- 3Enables clinicians to stratify mortality risk and inform personalized postchemotherapy management decisions.
Scoring Rationale
Solid published ML prognostic study with interpretable features and good metrics; limited by single-center retrospective cohort and need for external validation.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
